Home > Insider Trading > Filing (0001576280-25-000213)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753159	Amirali Talasaz	3100 Hanover Street Palo Alto CA 94304	Co-Chief Executive Officer	Yes	Yes	No	No

Transaction Summary

Sold:	100,000 shares	Avg. Price: $50.88	Total Value: $5,087,629.74
Number of Shares After Transactions:	1,983,665 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-06-30	4,815	$0.00	2,074,271	No	4	M	Direct
Common Stock	Disposition	2025-06-30	2,441	$52.04	2,071,830	No	4	F	Direct
Common Stock	Disposition	2025-07-01	72,068	$50.67	1,999,762	No	4	S	Direct
Common Stock	Disposition	2025-07-01	27,932	$51.40	1,971,830	No	4	S	Direct
Common Stock	Acquisiton	2025-07-01	23,997	$0.00	1,995,827	No	4	M	Direct
Common Stock	Disposition	2025-07-01	12,162	$50.71	1,983,665	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2025-06-30	4,815	$0.00	4,815	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-07-01	23,997	$0.00	23,997	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,629			No	4	M	Direct
143,983			No	4	M	Direct

Footnotes

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.08 to $51.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.08 to $51.94 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
Not applicable for Restricted Stock Units.
This restricted stock unit award vested with respect to 1/3 of the shares on January 1, 2025. The remaining shares vest quarterly for the remaining twenty-four months.